Immunohistochemical localization of types 1 and 2 5α-reductase in human scalp
September 1999
in “British Journal of Dermatology”
TLDR The study found that two enzymes linked to hair loss are located in different parts of the scalp, supporting a common treatment's effectiveness.
The 1999 study investigated the distribution of 5α-reductase isozymes in the human scalp, with a focus on their role in androgenetic alopecia. It found that type 1 5α-reductase (5αR1) is predominantly located in sebaceous glands, while type 2 5α-reductase (5αR2) is localized within hair follicles, specifically in the inner layer of the outer root sheath and the infundibular region. The presence of 5αR2 in hair follicles supports the effectiveness of finasteride, a 5αR2 inhibitor, in treating male pattern hair loss by acting locally at the follicular level. The study did not specify the number of participants but focused on the cellular and molecular localization of these enzymes.
View this study on academic.oup.com →
Cited in this study
research Different Levels of 5α-Reductase Type I and II, Aromatase, and Androgen Receptor in Hair Follicles of Women and Men with Androgenetic Alopecia
People with hair loss have more androgen receptors and enzymes in certain follicles, with men and women showing different patterns.
research Inhibition of Hair Growth by Testosterone in the Presence of Dermal Papilla Cells from the Frontal Bald Scalp of the Postpubertal Stumptailed Macaque
Testosterone can slow hair growth in adult monkeys, but a blocker called RU 58841 can counteract this and potentially help hair regrow.
research The Effect of Finasteride in Men with Benign Prostatic Hyperplasia
Finasteride effectively treats BPH but may increase sexual dysfunction risk.
Related
research Immunohistochemical localization of types 1 and 2 5α-reductase in human scalp
The study found that two enzymes linked to hair loss are located in different parts of the scalp, supporting a common treatment's effectiveness.